Levemir and Lantus are both long-acting injectable insulins that can be used for long-term management of diabetes. Insulin is a hormone that is naturally produced in the body by the pancreas.

In this article, we review the main similarities and differences between Levemir and Lantus. If you’re considering taking one of these medications, be sure to talk with your doctor. Discussing ...

Levemir is one of three types of long-acting "basal" insulins, but it doesn't last in the body as long as other basal versions. Lantus lasts 24 to 36 hours, and Tresiba lasts up to 42 hours.

15% below the list price of Lantus. The companies also hope to steal market share from Novo Nordisk, undercutting the long-acting Levemir (insulin detemir) by 21% and Tresiba (insulin degludec ...

Two other, long-acting "basal" insulins on the market include Sanofi's Lantus and Novo Nordisk's Tresiba. When Levemir is no longer available to U.S. consumers, the senators asked whether the ...

Novo Nordisk's decision has been criticized by some patients with Type 1 diabetes who prefer Levemir over other long-acting "basal" insulins such as Sanofi's Lantus and Novo Nordisk's Tresiba.

Researchers identified 10,458 adults with type 2 diabetes (T2D) who switched from using any other long-acting insulin to Toujeo, Lantus, or Levemir, and created matched cohorts by demographic and ...

It's called Basaglar, and it is 15% less than the list price of Lantus and Toujeo, two long-acting insulins made by Sanofi Aventis, 21% less than the list price of Levemir, and 28% less than ...